_version_ 1785090476155600896
author Bahlis, Nizar J
Weisel, Katja
Mateos, Maria-Victoria
Goldschmidt, Hartmut
Martin, Tom
Morillo, Daniel
Reece, Donna
Rodríguez-Otero, Paula
Bhutani, Manisha
D’souza, Anita
Oriol, Albert
Rosiñol Dachs, Laura
Dholaria, Bhagirathbhai
Bakshi, Kalpana
Kang, Lijuan
Vandenberk, Lien
Smit, Damiette
Wäsch, Ralph
van de Donk, Niels W.C.J.
Chari, Ajai
author_facet Bahlis, Nizar J
Weisel, Katja
Mateos, Maria-Victoria
Goldschmidt, Hartmut
Martin, Tom
Morillo, Daniel
Reece, Donna
Rodríguez-Otero, Paula
Bhutani, Manisha
D’souza, Anita
Oriol, Albert
Rosiñol Dachs, Laura
Dholaria, Bhagirathbhai
Bakshi, Kalpana
Kang, Lijuan
Vandenberk, Lien
Smit, Damiette
Wäsch, Ralph
van de Donk, Niels W.C.J.
Chari, Ajai
author_sort Bahlis, Nizar J
collection PubMed
description
format Online
Article
Text
id pubmed-10428465
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284652023-08-17 S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS Bahlis, Nizar J Weisel, Katja Mateos, Maria-Victoria Goldschmidt, Hartmut Martin, Tom Morillo, Daniel Reece, Donna Rodríguez-Otero, Paula Bhutani, Manisha D’souza, Anita Oriol, Albert Rosiñol Dachs, Laura Dholaria, Bhagirathbhai Bakshi, Kalpana Kang, Lijuan Vandenberk, Lien Smit, Damiette Wäsch, Ralph van de Donk, Niels W.C.J. Chari, Ajai Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428465/ http://dx.doi.org/10.1097/01.HS9.0000967680.90062.ca Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Bahlis, Nizar J
Weisel, Katja
Mateos, Maria-Victoria
Goldschmidt, Hartmut
Martin, Tom
Morillo, Daniel
Reece, Donna
Rodríguez-Otero, Paula
Bhutani, Manisha
D’souza, Anita
Oriol, Albert
Rosiñol Dachs, Laura
Dholaria, Bhagirathbhai
Bakshi, Kalpana
Kang, Lijuan
Vandenberk, Lien
Smit, Damiette
Wäsch, Ralph
van de Donk, Niels W.C.J.
Chari, Ajai
S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title_full S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title_fullStr S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title_full_unstemmed S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title_short S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
title_sort s192: talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (rrmm): updated trimm-2 results
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428465/
http://dx.doi.org/10.1097/01.HS9.0000967680.90062.ca
work_keys_str_mv AT bahlisnizarj s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT weiselkatja s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT mateosmariavictoria s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT goldschmidthartmut s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT martintom s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT morillodaniel s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT reecedonna s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT rodriguezoteropaula s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT bhutanimanisha s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT dsouzaanita s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT oriolalbert s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT rosinoldachslaura s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT dholariabhagirathbhai s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT bakshikalpana s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT kanglijuan s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT vandenberklien s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT smitdamiette s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT waschralph s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT vandedonknielswcj s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results
AT chariajai s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results